What is Alumis Inc.'s change in AP?

Alumis Inc. (ALMS) reported change in AP of $1.43M in Q1 2026.

How has Alumis Inc.'s change in AP changed year-over-year?

Alumis Inc.'s change in AP increased by 166.6% year-over-year, from -$2.15M to $1.43M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Alumis Inc. ALMS Change in AP

Change in AP at other companies

Bristol-Myers SquibbBMY

$409M+581%

AmgenAMGN

$571M+14.9%

ANI PharmaceuticalsANIP

$5.36M-3.4%

Celldex TherapeuticsCLDX

-$287K+96.7%

ImmunomeIMNM

$1.42M+137%

Nektar TherapeuticsNKTR

-$934K-115%

Other financials

Income statement

See full

Revenue$1.7M-90.0%

Operating income-$98.4M+3.1%

Net income-$93.1M+6.0%

EPS (diluted)-$0.74+59.3%

Balance sheet

See full

Cash & equivalents$63.9M-50.3%

Total debt$35.7M+1,881%

Total equity$567.0M+237%

Total assets$671.6M+157%

Cash flow

See full

Operating cash flow-$87.1M-8.4%

CapEx$164.0K+343%

Free cash flow-$87.2M-8.5%

Valuation

See full

Market cap$3.12B+739%

Enterprise value$3.1B+1,238%

P/S371.9×—

Profitability

See full

Operating margin-5,364%—

Net margin-2,825.7%—

FCF margin-4,487.4%—

Returns & leverage

See full

Return on equity-64.6%—

Debt / equity0.1×+0.1×

Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableTrade.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alumis Inc.'s change in AP?: Alumis Inc. (ALMS) reported change in AP of $1.43M in Q1 2026.
How has Alumis Inc.'s change in AP changed year-over-year?: Alumis Inc.'s change in AP increased by 166.6% year-over-year, from -$2.15M to $1.43M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.